10 research outputs found
Vitamin D deficiency prevalence in summer compared to winter in a city with high humidity and a sultry climate
Background: Vitamin D deficiency is high in winter because of reduced exposure to sunlight. It seems that in places with high humidity
and a sultry climate, exposure to sunlight in summer can be low too. This study was designed to determine the vitamin D deficiency
prevalence in Sari, a city with a high humidity climate at the end of summer, and compare it to winter.
Material and methods: This cross-sectional study was carried out on men and women aged 10 to 70. Clustered blood samples were received
from 351 subjects who participated in this study toward the end of summer, and in winter. The levels of serum vitamin D, calcium,
phosphorus, alkaline phosphatase and PTH were measured. T test and X2 were used for data analysis.
Results: 351subjects (66.4% women, 33.6% men) aged 11 to 69 (mean age ± SD 37.11 ± 12.6) participated in the study. The mean 25-(OH)
D concentration in summer was 13.41 ± 13, and in winter it was 11.7 ± 11, and the difference was statistically significant (p < 0.02). The
prevalence of 25-OHvitamin D deficiency was 87.5% (307) in winter and 78.6% (276) in summer (p < 0.05).
Conclusion: This study shows that although in this area with a high humidity climate, seasonal variation of vitamin D is statistically significant,
the prevalence of Vitamin D insufficiency is as high in summer as in winter. (Pol J Endocrinol 2011; 62 (3): 249–251)Background: Vitamin D deficiency is high in winter because of reduced exposure to sunlight. It seems that in places with high humidity
and a sultry climate, exposure to sunlight in summer can be low too. This study was designed to determine the vitamin D deficiency
prevalence in Sari, a city with a high humidity climate at the end of summer, and compare it to winter.
Material and methods: This cross-sectional study was carried out on men and women aged 10 to 70. Clustered blood samples were received
from 351 subjects who participated in this study toward the end of summer, and in winter. The levels of serum vitamin D, calcium,
phosphorus, alkaline phosphatase and PTH were measured. T test and X2 were used for data analysis.
Results: 351subjects (66.4% women, 33.6% men) aged 11 to 69 (mean age ± SD 37.11 ± 12.6) participated in the study. The mean 25-(OH)
D concentration in summer was 13.41 ± 13, and in winter it was 11.7 ± 11, and the difference was statistically significant (p < 0.02). The
prevalence of 25-OHvitamin D deficiency was 87.5% (307) in winter and 78.6% (276) in summer (p < 0.05).
Conclusion: This study shows that although in this area with a high humidity climate, seasonal variation of vitamin D is statistically significant,
the prevalence of Vitamin D insufficiency is as high in summer as in winter. (Pol J Endocrinol 2011; 62 (3): 249–251
A successful pregnancy for a young hypothyroid woman with Gitelman Syndrome: A rare case study report
It is widely assumed that Gitelman syndrome is a rare genetic disorder with such electrolyte imbalance as hypokalemia and hypomagnesaemia. The impact of hypothyroidism on Gitelman syndrome and its management is not clear. In this case study, a hypothyroid young woman referred to our endocrine clinic for muscle cramp after the hypothyroidism management. Based on Laboratory and clinical findings, the woman was diagnosed to have been suffering from Gitelman syndrome and the treatment with magnesium, potassium and oral Spironolactone began immediately. After two years of treatment, the woman experienced a successful planned pregnancy
Frequency of burning mouth and subjective xerostomia in patients with diabetes mellitus type 2
Background: Diabetes mellitus is a common chronic metabolic disease which have numerous
physical effects for patients.
Objective: The aim of this study was to determine the prevalence of subjective xerostomia and
burning mouth of patients with type 2 diabetes mellitus in cities of Sari and Qaemshahr.
Methods: In this descriptive-analytic study, totally 1455 patients with type 2 diabetes mellitus with
complain of xerostomia and/or burning mouth which had referred to diabetes clinic in Sari and
Qaemshahr were examined in 2016. For every patient asked about chronic xerostomia and burning
mouth and if the answer was positive, the oral examination was done to ensure the absence of
mucosal lesions and find signs of xerostomia. Then, xerostomia questionnaire was completed by
patients suffering from dry mouth. Finally, the information was statistically analyzed by T test and
chi square test.
Findings: Prevalence of burning mouth was found 111 (7.6%) in diabetic patients that in the
women were significantly higher than in men (P<0.0001). Prevalence of xerstomia patients was
found 239 (16.4%) that was not significant between the male and female. There was a significant
correlation between burning mouth and xerostomia with FBS and HbA1c in diabetic patients
(P<0.0001).
Conclusion: Possibility of burning mouth, and xerostomia will increase in the diabetic patients with
low metabolic control which can cause more severe side effects related to oral health.
Keywords: Diabetes mellitus, Xerostomia, Burning mouth syndrom
A Study on 6-18 years-old girl students a bout weight and height in Sari
(Received 19 May, 2008; Accepted 14 Jan, 2008) Abstract Background and purpose: Measurement of height and weight of children and adolescents are important sources of information and the best index for evaluation of their growth and nutritional and health status of society. This study performed to evaluate weight, height and pubertal stage of girls in sari. Materials and methods: This cross – sectional study was performed on 1320 6-18 years old school girls in elementary guidance and high school of Sari. Their height, weight and pubertal stage were evaluated and recorded by educated personas . Also Body Mass Index was calculated and recorded. Then Z score (SDS) of weight, height and the Body Mass Index studied people was compared by using calculated standard curve and findings in NCHS curve and findings of 1997 in Sari.For analyzing data, descriptive statistics, Mean±SD, Frequency and percent were used.Results: By using NCHS curve 1256 persons ( 95. 2 % ) from total persons that were studied , had normal height ( 5 – 95 percentile ) and the weight of 1254 persons ( 95 % ) were in 5 - 95 percentile . 2/5 centemers increasing in height and 2.5 Kg increasing in weight were seen in comparison to 1997 study .BMI of persons in all age groups ( expect 17 year old with ± 0.05 SD )were over than 50 percentile and mean age of beginning of menarche was 11.4 ± 1.1 .Conclusion: Our study in Sari shows the improvement in growth index in comparison to 1997 study which become near to standard curve in developed country
Pachydermoperiostosis in a Patient with Crohn’s Disease: Treatment and Literature Review
Pachydermoperiostosis (PDP) is a rare disorder characterized by pachydermia, digital clubbing, periostitis, and an excess of affected males. It is the primary form of hypertrophic osteoarthropathy (HOA) and there are some rare associations of PDP with other disorders. Here we describe a patient with Crohn’s disease associated with PDP. A 26-year-old man, who was a known case of Crohn’s disease, referred with diffuse swelling in the upper and lower limbs and cutis verticis gyrata since 7 years ago. PDP was suspected and endocrinological and radiological studies were conducted for the evaluation of underlying disease. He was prescribed celecoxib, low-dose prednisolone, and pamidronate to control the swelling, periostitis, azathiopurine, and mesalazine according to gastrointestinal involvement. In conclusion, it is important to identify this condition since a misdiagnosis might subject the patient to unnecessary investigations
Therapeutic Outcomes of Hyperthyroidism: A Ten-year Investigation in an Endocrine Clinic in North of Iran
Materials and methods: This descriptive study included all hyperthyroid patients. All therapeutic results were recorded and analyzed.
Results: In this study, 329 records were studied and 104 patients met the study inclusion criteria. Graves' disease (GD) and toxic adenoma were reported in 94% and 6%, respectively. Among the patients with GD, 30.5% (21.7-40.3%) did not respond to initial ATD treatment and 20% had recurrent GD despite appropriate initial response. Overall, antithyroid drugs failure occurred in 50.5% (40.45-60.55%) of the patients. Lower age, lower body mass index (BMI), high thyroid weight, and higher baseline thyroid hormone levels were associated with ATD failure (P <0.05). Patients with toxic adenomas and patients who did not respond to ATD or those who experienced relapse of hyperthyroidism received radioactive iodine or underwent surgery. Hypothyroidism occurred in 13.1% of patients with ATD alone, in 66.7% of those with surgery, and in 79.4% of the patients who received radioactive iodine (P= 0.0001).
Conclusion: A significant proportion of hyperthyroid patients experience drug failure. Age, BMI, thyroid weight, and basal levels of thyroid hormones are associated with drug treatment failure. Prevalence of hypothyroidism after treatment with radioactive iodine is higher than the drug treatment alone or surgery groups
The effect of xerostomia and hyposalivation on the quality of life of patients with type II diabetes mellitus
Background: Diabetes mellitus is a chronic metabolic disease which can have numerous physical effects for
patient. Xerostomia is one of these complications. Compared to healthy people, patients with diabetes mellitus,
have a worse quality of life, and complications of diabetes are the main determinants of quality of life in these
patients.
Objective: The aim of this study was to determine the effects of xerostomia and hyposalivation on quality of life
of patients with type 2 diabetes mellitus.
Methods: This descriptive-analytical epidemiological study was conducted on 200 patients with type 2 diabetes
mellitus referred to the diabetes clinic of Shahid Mostafavi in Sari city from October 2015 to January in 2016. A
questionnaire containing personal characteristics and medical situation was completed by each person. Then, the
Persian Oral Health Impact Profile-14 (OHIP-14-PER) questionnaire was completed by the patients. Eventually,
with the use of chewable paraffin for 1.5 min by the patient, stimulated salivary flow rate (SSFR) test was
performed, and in order to determine hyposalivation, their saliva amount underwent a gravimetric test. Finally,
using statistical software SPSS16, the information was statistically analyzed by independent-samples t-test,
Mann-Whitney U, Chi-squared and fisher exact tests.
Results: The average age of patient was 56.41 years old (43% male and 57% female). Mean SSFR was 0.7
ml/min in patients and xerostomia were confirmed in 112 patients. Difference between age, gender, drug use,
years affecting to diabetes and FBS amount in patient with hyposalivation were not statistically meaningful in
proportion to patients without it. But difference between HbA1C and SSFR in patients with hyposalivation were
statistically meaningful than to patients without it (p=0.03, p=0.001 respectively). The mean patient score to
OHIP-14 were obtained as 38.17. The questionnaire score difference in patients with hyposalivation in proportion
to patients without it were not statistically meaningful.
Conclusion: Hyposalivation possibility increases in diabetic patients with low metabolic control which can cause
more severe side effects in relation to oral health. Xerostomia in diabetic patients has negative effects on oral
health related quality of life. Diabetic control and patients’ oral problem improvement is effective in their quality
of life promotio
Evaluation of levothyroxine effect on pulmonary function inhypothyroidism
(Received 14 Jul, 2008; Accepted 12 Nov, 2008) Abstract Background and purpose: Hypothyroidism is one of the most common diseases in endocrinology Thyroid hormone deficiency effects on nerve and muscle fibers, pulmonary system and alveolar ventilation. The aim of this study was to evaluate the effect of Levothyroxine therapy on pulmonary function in hypothyroidism patients in Imam Hospital.Materials and methods: This study was performed on 50 patients with hypothyroidism in Imam Hospital, Sari, Iran, 2006-2007. After a detailed clinical history and systemic examination, level of TSH, T4 and ABG test, chest radiography and spirometery was performed in all patients. The spirometery indexes including FVC, FEV1, FEV1/FVC, FEF 25-75, PEF were recorded. All patients treated with Levothyroxine 1.6μg/kg. After that all systemic and clinical examination, and chest radiography and spirometery performed again. Results analyzed by means of SPSS (11) software and paired t test. The p value less than 0.05 was considered to be significant statisticallyResults: 50 female patients, with mean age of 34.98±13.4 years were studied. The mean of TSH, T4 before treatment were 51.44±25.3 mIu/l and 2.8± 0.9 μg/dl and after treatment were 3.64±2.4 mIu/l and 9.80±4.9 μg/dl respectively (P= 0.0001). The ABG parameters were in normal range and there was no statistically significant difference between before and after treatment. Statistical analysis demonstrated significant differences between mean of FVC, FEV1, FEV1/FVC, FEF 25-75, and PEF before and after treatment.Conclusion: Our study demonstrates that treatment of hypothyroidism with Levothyroxine can improves the pulmonary function according to spirometery findings
Effects of tarragon powder on glucose metabolic changes, lipid profile and antioxidant enzyme levels in type 2 patients with diabetes: A randomized, double-blind, placebo-controlled, clinical trial
Background: The antioxidant and anti-inflammatory properties of tarragon make it known as an antidiabetic plant. Diabetes mellitus, an endocrine, metabolic disease, is a leading global health emergency and associated with serious complications.
Objectives: This study aimed to assess the effects of tarragon powder supplementation on glucose metabolism, lipid profile, and
antioxidant status in the diabetic population.
Methods: Patient screening and selection for this clinical trial lasted one month. Tarragon supplement consumption by patients
lasted 2 months (8 weeks); meanwhile, they were followed up. Sixty male and female patients with type 2 diabetes were randomly
assigned to the tarragon receiver group (n = 30) and placebo receiver group (n = 30). The intervention group received a tarragon
capsule (500 mg) 3 times a day, and the control group received placebo capsules. Fasting blood glucose (FBG), two-hour postprandial
glucose (2-hpp), glycated hemoglobin (HbA1c), insulin, lipid, and antioxidant profile were evaluated at the start and the end of the
research.
Results: In the tarragon receiver group, FBG, 2-hpp, HbA1c%, insulin resistance, lipid, and antioxidant profile significantly improved,
compared to the placebo group, after adjuvant therapy with tarragon (P < 0.05).
Conclusions: Supplementation with tarragon powder in type II patients with diabetes for 2 months exerts a beneficial effect on
improving the glycemic profile, lipid profile, and antioxidant statu